Kedrion Biopharma expands to North America with Prometic acquisition

By Nikita Chaurasia  Date: 2021-10-19

Kedrion Biopharma expands to North America with Prometic acquisition
  • Prometic Life Sciences has developed the first FDA-approved treatment for Congenital Plasminogen Deficiency.
  • This acquisition will enable easy access to advanced therapies for patients suffering from this rare disease.

Kedrion Biopharma Inc. has reportedly acquired Canada-based biopharmaceutical company Liminal BioSciences Inc. previously known as Prometic Life Sciences, as a part of the plans to expand its reach in North America.

The company is also working towards a launch in the United States in 2022, cited sources with reliable information.

For the record, Liminal BioSciences Inc. employs 130 people in Quebec and has developed the first FDA-certified treatment option for Congenital Plasminogen Deficiency. The new drug, named Ryplazim, can be used to treat Plasminogen Deficiency which can cause respiratory failure, blindness, and other chronic complications.

Chairperson of Kedrion Biopharma, Paolo Marcucci was quoted saying that the acquisition will ensure that patients suffering from this rare disease have easy access to treatment. He also claimed that the deal is a part of the company’s strategy to expand its reach in North America – a region from which the company derives nearly 50% of its revenues.

With the acquisition, Kedrion Biopharma has completed a series of transactions which the company started in June 2020, including the purchase of Liminal’s plasma purification plant at Laval in Quebec, and the license to distribute Ryplazim in the United States.

Chief Executive Officer of Kedrion Biopharma, Val Romberg reportedly said that the development & distribution of Ryplazim allows the company to fulfill the mission of putting patients first. This is the first FDA-approved drug for Type 1 Congenital Plasminogen Deficiency, and the company is honored to help speed its distribution in the market, he added.

In addition to the Quebec plant, Kedrion Biopharma also acquired two new plasma collection centers located in Winnipeg, Manitoba, and Amherst, New York as a part of this agreement.

Source Credits—

https://www.prnewswire.com/news-releases/kedrion-biopharama-grows-in-north-america-as-it-completes-acquisition-of-prometic-301401799.html

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Canada limits 5G around airports over aircraft interference concerns

Canada limits 5G around airports over aircraft interference concerns

By Nikita Chaurasia

Much to the surprise of the telecom industry, the Department of Innovation, Science, and Economic Development (ISED) of Canada has reportedly decided to limit some 5G services that could possibly interfere with radio altimeters, which are crucial com...

U.S. planning to invest billions to expand COVID-19 vaccine production

U.S. planning to invest billions to expand COVID-19 vaccine production

By Nikita Chaurasia

The United States is reportedly planning to make substantial investments to improve its COVID-19 vaccine manufacturing capacity. The country intends to produce at least a billion doses by the second half of 2022. This decision is driven by the huge ...

Peloton sues rival firms iFit and Echelon for patent infringement

Peloton sues rival firms iFit and Echelon for patent infringement

By Nikita Chaurasia

U.S.-based exercise equipment and media company Peloton Interactive Inc. has reportedly filed lawsuits against its rivals Echelon Fitness and iFit, claiming that they violated patents related to its on-demand classes. Peloton stated that Echelon and...

Apple’s digital ID card plan could be funded through states, taxpayers

Apple’s digital ID card plan could be funded through states, taxpayers

By Nikita Chaurasia

Apple is reportedly working on allowing users in participating states to digitally store their state IDs  or driver’s licenses on their iPhone wallet. However, the multibillion-dollar company will partially rely on the respective states &m...

South Korea demonstrates systems for urban air mobility management

South Korea demonstrates systems for urban air mobility management

By Nikita Chaurasia

South Korea has reportedly tested methods for operating urban air mobility (UAM) vehicles, which it aims to use for taxis that will fly between downtown Seoul and major airports as early as 2025. In 2020, South Korea had announced its plan to launch...